# Glucagon Resistance in Patients With MASLD and T2DM

> **NCT07246421** · NA · RECRUITING · sponsor: **University of Aarhus** · enrollment: 24 (estimated)

## Conditions studied

- Metabolic Associated Fatty Liver Disease
- Type 2 Diabetes (T2DM)

## Interventions

- **OTHER:** Glugagon

## Key facts

- **NCT ID:** NCT07246421
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-29
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07246421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07246421, "Glucagon Resistance in Patients With MASLD and T2DM". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07246421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*